Terns Pharmaceuticals, Inc. (TERN)
40.59
-0.91
(-2.19%)
USD |
NASDAQ |
Dec 30, 16:00
40.50
-0.09
(-0.22%)
Pre-Market: 08:59
Terns Pharmaceuticals EPS Diluted (Quarterly): -0.2686 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Altimmune, Inc. | -0.2126 |
| Ligand Pharmaceuticals, Inc. | 5.685 |
| ADMA Biologics, Inc. | 0.1489 |
| Viking Therapeutics, Inc. | -0.8083 |
| Cidara Therapeutics, Inc. | -3.096 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -24.64M |
| Total Expenses (Quarterly) | 24.64M |
| Enterprise Value | 3.362B |
| Earnings Yield | -2.54% |
| Normalized Earnings Yield | -2.542 |